-
1
-
-
48249097797
-
Endocannabinoids: Synthesis and degradation
-
Di Marzo, V. Endocannabinoids: synthesis and degradation. Rev. Physiol. Biochem. Pharmacol. 160, 1-24 (2008).
-
(2008)
Rev. Physiol. Biochem. Pharmacol.
, vol.160
, pp. 1-24
-
-
Di Marzo, V.1
-
2
-
-
0242268553
-
The molecular logic of endocannabinoid signaling
-
Piomelli, D. The molecular logic of endocannabinoid signaling. Nat. Rev. Neurosci. 4, 873-884 (2003).
-
(2003)
Nat. Rev. Neurosci.
, vol.4
, pp. 873-884
-
-
Piomelli, D.1
-
3
-
-
44849141696
-
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
-
Ahn, K., McKinney, M.K. & Cravatt, B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 108, 1687-1707 (2008).
-
(2008)
Chem. Rev.
, vol.108
, pp. 1687-1707
-
-
Ahn, K.1
McKinney, M.K.2
Cravatt, B.F.3
-
4
-
-
34548050674
-
Understanding metabolic homeostasis and imbalance: What is the role of the endocannabinoid system?
-
Kunos, G. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system? Am. J. Med. 120, S18-S24 (2007).
-
(2007)
Am. J. Med.
, vol.120
-
-
Kunos, G.1
-
5
-
-
79955632246
-
Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
-
Di Marzo, V., Piscitelli, F. & Mechoulam, R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb. Exp. Pharmacol. 203, 75-104 (2011).
-
(2011)
Handb. Exp. Pharmacol.
, vol.203
, pp. 75-104
-
-
Di Marzo, V.1
Piscitelli, F.2
Mechoulam, R.3
-
7
-
-
33845344400
-
Endocannabinoid mechanisms of pain modulation
-
Hohmann, A.G. & Suplita, R.L. II. Endocannabinoid mechanisms of pain modulation. AAPS J. 8, E693-E708 (2006).
-
(2006)
AAPS J.
, vol.8
-
-
Hohmann, A.G.1
Suplita, I.I.R.L.2
-
8
-
-
0036019413
-
Endocannabinoids in cognition and dependence
-
Lichtman, A.H., Varvel, S.A. & Martin, B.R. Endocannabinoids in cognition and dependence. Prostaglandins Leukot. Essent. Fatty Acids 66, 269-285 (2002).
-
(2002)
Prostaglandins Leukot. Essent. Fatty Acids
, vol.66
, pp. 269-285
-
-
Lichtman, A.H.1
Varvel, S.A.2
Martin, B.R.3
-
9
-
-
45149111341
-
Adaptations in endocannabinoid signaling in response to repeated homotypic stress: A novel mechanism for stress habituation
-
Patel, S. & Hillard, C.J. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur. J. Neurosci. 27, 2821-2829 (2008).
-
(2008)
Eur. J. Neurosci.
, vol.27
, pp. 2821-2829
-
-
Patel, S.1
Hillard, C.J.2
-
10
-
-
59349084762
-
Endocannabinoid signals in the control of emotion
-
Lutz, B. Endocannabinoid signals in the control of emotion. Curr. Opin. Pharmacol. 9, 46-52 (2009).
-
(2009)
Curr. Opin. Pharmacol.
, vol.9
, pp. 46-52
-
-
Lutz, B.1
-
11
-
-
33947591537
-
The endocannabinoid system in targeting inflammatory neurodegenerative diseases
-
Centonze, D., Finazzi-Agro, A., Bernardi, G. & Maccarrone, M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol. Sci. 28, 180-187 (2007).
-
(2007)
Trends Pharmacol. Sci.
, vol.28
, pp. 180-187
-
-
Centonze, D.1
Finazzi-Agro, A.2
Bernardi, G.3
Maccarrone, M.4
-
12
-
-
78649233198
-
Cannabinoid receptors and endocannabinoids: Role in neuroinflammatory and neurodegenerative disorders
-
Bisogno, T. & Di Marzo, V. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 9, 564-573 (2010).
-
(2010)
CNS Neurol. Disord. Drug Targets
, vol.9
, pp. 564-573
-
-
Bisogno, T.1
Di Marzo, V.2
-
13
-
-
34249933789
-
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion
-
Bifulco, M., Laezza, C., Gazzerro, P. & Pentimalli, F. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion. Oncol. Rep. (review ) 17, 813-816 (2007).
-
(2007)
Oncol. Rep. (Review )
, vol.17
, pp. 813-816
-
-
Bifulco, M.1
Laezza, C.2
Gazzerro, P.3
Pentimalli, F.4
-
14
-
-
12344307361
-
Involvement of cannabinoids in cellular proliferation
-
López-Rodriguez, M.L., Viso, A., Ortega-Gutierrez, S. & Diaz-Laviada, I. Involvement of cannabinoids in cellular proliferation. Mini Rev. Med. Chem. 5, 97-106 (2005).
-
(2005)
Mini Rev. Med. Chem.
, vol.5
, pp. 97-106
-
-
López-Rodriguez, M.L.1
Viso, A.2
Ortega-Gutierrez, S.3
Diaz-Laviada, I.4
-
15
-
-
33747598488
-
Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling
-
Tam, J. et al. Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol. Pharmacol. 70, 786-792 (2006).
-
(2006)
Mol. Pharmacol.
, vol.70
, pp. 786-792
-
-
Tam, J.1
-
16
-
-
0029904838
-
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
-
Cravatt, B.F. et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87 (1996).
-
(1996)
Nature
, vol.384
, pp. 83-87
-
-
Cravatt, B.F.1
-
17
-
-
57749087828
-
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
-
Long, J.Z. et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 5, 37-44 (2009).
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 37-44
-
-
Long, J.Z.1
-
18
-
-
35649018143
-
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
-
Mangieri, R.A. & Piomelli, D. Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. Pharmacol. Res. 56, 360-366 (2007).
-
(2007)
Pharmacol. Res.
, vol.56
, pp. 360-366
-
-
Mangieri, R.A.1
Piomelli, D.2
-
19
-
-
79959977058
-
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats
-
Sciolino, N.R., Zhou, W. & Hohmann, A.G. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2- arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacol. Res. 64, 226-234 (2011).
-
(2011)
Pharmacol. Res.
, vol.64
, pp. 226-234
-
-
Sciolino, N.R.1
Zhou, W.2
Hohmann, A.G.3
-
20
-
-
80855138052
-
Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: A potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation
-
Sumislawski, J.J., Ramikie, T.S. & Patel, S. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 36, 2750-2761 (2011).
-
(2011)
Neuropsychopharmacology
, vol.36
, pp. 2750-2761
-
-
Sumislawski, J.J.1
Ramikie, T.S.2
Patel, S.3
-
21
-
-
34247605930
-
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality
-
Naidu, P.S. et al. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl.) 192, 61-70 (2007).
-
(2007)
Psychopharmacology (Berl.)
, vol.192
, pp. 61-70
-
-
Naidu, P.S.1
-
22
-
-
0037234363
-
Modulation of anxiety through blockade of anandamide hydrolysis
-
Kathuria, S. et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9, 76-81 (2003).
-
(2003)
Nat. Med.
, vol.9
, pp. 76-81
-
-
Kathuria, S.1
-
23
-
-
67650088165
-
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs
-
Gaetani, S. et al. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Int. Rev. Neurobiol. 85, 57-72 (2009).
-
(2009)
Int. Rev. Neurobiol.
, vol.85
, pp. 57-72
-
-
Gaetani, S.1
-
24
-
-
19444372967
-
Therapeutic opportunities through modulation of the endocannabinoid system
-
Makriyannis, A., Mechoulam, R. & Piomelli, D. Therapeutic opportunities through modulation of the endocannabinoid system. Neuropharmacology 48, 1068-1071 (2005).
-
(2005)
Neuropharmacology
, vol.48
, pp. 1068-1071
-
-
Makriyannis, A.1
Mechoulam, R.2
Piomelli, D.3
-
25
-
-
67449119913
-
The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
-
Di Marzo, V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res. 60, 77-84 (2009).
-
(2009)
Pharmacol Res.
, vol.60
, pp. 77-84
-
-
Di Marzo, V.1
-
26
-
-
21344432777
-
The endocannabinoid system: A drug discovery perspective
-
Piomelli, D. The endocannabinoid system: a drug discovery perspective. Curr. Opin. Investig. Drugs 6, 672-679 (2005).
-
(2005)
Curr. Opin. Investig. Drugs
, vol.6
, pp. 672-679
-
-
Piomelli, D.1
-
27
-
-
0034721794
-
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
-
Kozak, K.R., Rowlinson, S.W. & Marnett, L.J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J. Biol. Chem. 275, 33744-33749 (2000).
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 33744-33749
-
-
Kozak, K.R.1
Rowlinson, S.W.2
Marnett, L.J.3
-
28
-
-
43749115768
-
Non-redundant functions of cyclooxygenases: Oxygenation of endocannabinoids
-
Rouzer, C.A. & Marnett, L.J. Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J. Biol. Chem. 283, 8065-8069 (2008).
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 8065-8069
-
-
Rouzer, C.A.1
Marnett, L.J.2
-
29
-
-
3042785976
-
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus
-
Kim, J. & Alger, B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7, 697-698 (2004).
-
(2004)
Nat. Neurosci.
, vol.7
, pp. 697-698
-
-
Kim, J.1
Alger, B.E.2
-
30
-
-
78149234939
-
Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain
-
Glaser, S.T. & Kaczocha, M. Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain. J. Pharmacol. Exp. Ther. 335, 380-388 (2010).
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.335
, pp. 380-388
-
-
Glaser, S.T.1
Kaczocha, M.2
-
31
-
-
77952604813
-
Effects of COX-2 inhibition on spinal nociception: The role of endocannabinoids
-
Staniaszek, L.E., Norris, L.M., Kendall, D.A., Barrett, D.A. & Chapman, V. Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids. Br. J. Pharmacol. 160, 669-676 (2010).
-
(2010)
Br. J. Pharmacol.
, vol.160
, pp. 669-676
-
-
Staniaszek, L.E.1
Norris, L.M.2
Kendall, D.A.3
Barrett, D.A.4
Chapman, V.5
-
32
-
-
77956274926
-
R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids
-
Bishay, P. et al. R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS ONE 5, e10628 (2010).
-
(2010)
PLoS ONE
, vol.5
-
-
Bishay, P.1
-
33
-
-
80054953106
-
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
-
Duggan, K.C. et al. (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat. Chem. Biol. 7, 803-809 (2011).
-
(2011)
Nat. Chem. Biol.
, vol.7
, pp. 803-809
-
-
Duggan, K.C.1
-
34
-
-
68249100483
-
Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid
-
Prusakiewicz, J.J., Duggan, K.C., Rouzer, C.A. & Marnett, L.J. Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid. Biochemistry 48, 7353-7355 (2009).
-
(2009)
Biochemistry
, vol.48
, pp. 7353-7355
-
-
Prusakiewicz, J.J.1
Duggan, K.C.2
Rouzer, C.A.3
Marnett, L.J.4
-
35
-
-
0034681109
-
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors
-
Kalgutkar, A.S. et al. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. Proc. Natl. Acad. Sci. USA 97, 925-930 (2000).
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 925-930
-
-
Kalgutkar, A.S.1
-
36
-
-
73949109254
-
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
-
Long, J.Z. et al. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc. Natl. Acad. Sci. USA 106, 20270-20275 (2009).
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 20270-20275
-
-
Long, J.Z.1
-
37
-
-
78650619344
-
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
-
Kinsey, S.G., O'Neal, S.T., Long, J.Z., Cravatt, B.F. & Lichtman, A.H. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacol. Biochem. Behav. 98, 21-27 (2011).
-
(2011)
Pharmacol. Biochem. Behav.
, vol.98
, pp. 21-27
-
-
Kinsey, S.G.1
O'neal, S.T.2
Long, J.Z.3
Cravatt, B.F.4
Lichtman, A.H.5
-
38
-
-
77954902977
-
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition
-
Rossi, S. et al. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Mol. Pharmacol. 78, 260-268 (2010).
-
(2010)
Mol. Pharmacol.
, vol.78
, pp. 260-268
-
-
Rossi, S.1
-
39
-
-
37149050777
-
Reduced anxiety-like behavior induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
-
Moreira, F.A., Kaiser, N., Monory, K. & Lutz, B. Reduced anxiety-like behavior induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54, 141-150 (2008).
-
(2008)
Neuropharmacology
, vol.54
, pp. 141-150
-
-
Moreira, F.A.1
Kaiser, N.2
Monory, K.3
Lutz, B.4
-
40
-
-
33646829909
-
Behavioral methods in cannabinoid research
-
Fride, E., Perchuk, A., Hall, F.S., Uhl, G.R. & Onaivi, E.S. Behavioral methods in cannabinoid research. Methods Mol. Med. 123, 269-290 (2006).
-
(2006)
Methods Mol. Med.
, vol.123
, pp. 269-290
-
-
Fride, E.1
Perchuk, A.2
Hall, F.S.3
Uhl, G.R.4
Onaivi, E.S.5
-
41
-
-
35649008926
-
Cannabinoids go nuclear: Evidence for activation of peroxisome proliferator-activated receptors
-
O'Sullivan, S.E. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br. J. Pharmacol. 152, 576-582 (2007).
-
(2007)
Br. J. Pharmacol.
, vol.152
, pp. 576-582
-
-
O'sullivan, S.E.1
-
42
-
-
39149131360
-
Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain
-
Cristino, L. et al. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Neuroscience 151, 955-968 (2008).
-
(2008)
Neuroscience
, vol.151
, pp. 955-968
-
-
Cristino, L.1
-
43
-
-
33745261630
-
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling
-
Patel, S. & Hillard, C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J. Pharmacol. Exp. Ther. 318, 304-311 (2006).
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.318
, pp. 304-311
-
-
Patel, S.1
Hillard, C.J.2
-
44
-
-
47249109433
-
COX-2 inhibition in schizophrenia and major depression
-
Müller, N. & Schwarz, M.J. COX-2 inhibition in schizophrenia and major depression. Curr. Pharm. Des. 14, 1452-1465 (2008).
-
(2008)
Curr. Pharm. Des.
, vol.14
, pp. 1452-1465
-
-
Müller, N.1
Schwarz, M.J.2
-
45
-
-
80052784496
-
Managing the adverse effects of nonsteroidal anti-inflammatory drugs
-
Patrignani, P., Tacconelli, S., Bruno, A., Sostres, C. & Lanas, A. Managing the adverse effects of nonsteroidal anti-inflammatory drugs. Expert Rev. Clin. Pharmacol. 4, 605-621 (2011).
-
(2011)
Expert Rev. Clin. Pharmacol.
, vol.4
, pp. 605-621
-
-
Patrignani, P.1
Tacconelli, S.2
Bruno, A.3
Sostres, C.4
Lanas, A.5
-
46
-
-
84860703445
-
Vascular COX-2 modulates blood pressure and thrombosis in mice
-
Yu, Y. et al. Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci. Transl. Med. 4, 132ra154 (2012).
-
(2012)
Sci. Transl. Med.
, vol.4
-
-
Yu, Y.1
-
47
-
-
0034721194
-
Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors
-
Kalgutkar, A.S., Marnett, A.B., Crews, B.C., Remmel, R.P. & Marnett, L.J. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors. J. Med. Chem. 43, 2860-2870 (2000).
-
(2000)
J. Med. Chem.
, vol.43
, pp. 2860-2870
-
-
Kalgutkar, A.S.1
Marnett, A.B.2
Crews, B.C.3
Remmel, R.P.4
Marnett, L.J.5
-
48
-
-
0033551732
-
The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2) - A putative L-shaped binding conformation utilizing the top channel region
-
Rowlinson, S.W., Crews, B.C., Lanzo, C.A. & Marnett, L.J. The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2) - A putative L-shaped binding conformation utilizing the top channel region. J. Biol. Chem. 274, 23305-23310 (1999).
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 23305-23310
-
-
Rowlinson, S.W.1
Crews, B.C.2
Lanzo, C.A.3
Marnett, L.J.4
-
49
-
-
84887625214
-
Glyceryl prostaglandin synthesis in lipopolysaccharide-treated RAW264.7 cells is augmented by interferon-gamma and granulocytemacrophage colony stimulating factor
-
Rouzer, C.A. & Marnett, L.J. Glyceryl prostaglandin synthesis in lipopolysaccharide-treated RAW264.7 cells is augmented by interferon-gamma and granulocytemacrophage colony stimulating factor. Prostag. Oth. Lipid M. 79, 146-147 (2006).
-
(2006)
Prostag. Oth. Lipid M.
, vol.79
, pp. 146-147
-
-
Rouzer, C.A.1
Marnett, L.J.2
-
50
-
-
37149013708
-
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
-
Blankman, J.L., Simon, G.M. & Cravatt, B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347-1356 (2007).
-
(2007)
Chem. Biol.
, vol.14
, pp. 1347-1356
-
-
Blankman, J.L.1
Simon, G.M.2
Cravatt, B.F.3
-
51
-
-
64749114255
-
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain
-
Ahn, K. et al. Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem. Biol. 16, 411-420 (2009).
-
(2009)
Chem. Biol.
, vol.16
, pp. 411-420
-
-
Ahn, K.1
-
52
-
-
80051553181
-
Molecular characterization and identification of surrogate substrates for diacylglycerol lipase alpha
-
Pedicord, D.L. et al. Molecular characterization and identification of surrogate substrates for diacylglycerol lipase alpha. Biochem. Biophys. Res. Commun. 411, 809-814 (2011).
-
(2011)
Biochem. Biophys. Res. Commun.
, vol.411
, pp. 809-814
-
-
Pedicord, D.L.1
-
53
-
-
80053905361
-
Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer
-
Uddin, M.J. et al. Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer. Cancer Prev. Res. (Phila.) 4, 1536-1545 (2011).
-
(2011)
Cancer Prev. Res. (Phila.)
, vol.4
, pp. 1536-1545
-
-
Uddin, M.J.1
-
54
-
-
58149373942
-
D-2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling
-
Pan, B., Hillard, C.J. & Liu, Q.S. D-2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J. Neurosci. 28, 14018-14030 (2008).
-
(2008)
J. Neurosci.
, vol.28
, pp. 14018-14030
-
-
Pan, B.1
Hillard, C.J.2
Liu, Q.S.3
-
55
-
-
70449522985
-
Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala
-
Patel, S., Kingsley, P.J., Mackie, K., Marnett, L.J. & Winder, D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 34, 2699-2709 (2009).
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 2699-2709
-
-
Patel, S.1
Kingsley, P.J.2
Mackie, K.3
Marnett, L.J.4
Winder, D.G.5
-
56
-
-
38449122375
-
LC-MS-MS analysis of neutral eicosanoids
-
Kingsley, P.J. & Marnett, L.J. LC-MS-MS analysis of neutral eicosanoids. Methods Enzymol. 433, 91-112 (2007).
-
(2007)
Methods Enzymol.
, vol.433
, pp. 91-112
-
-
Kingsley, P.J.1
Marnett, L.J.2
|